Diamond Hill Capital’s Top 5 Stock Picks

Diamond Hill Capital is a fund managed by Ric Dillon which recently filed its 13F for the second quarter of 2012 with the SEC. Diamond Hill is one of the successful funds that have grown its assets under management into the billions as a result of its long-term investment approach based on fundamental value. Diamond Hill Capital doesn’t recommend or endorse any of the stocks or analysis in this article, and we have no relationship with the fund, but based on SEC filings these are our opinions of what they are thinking. Read on to see the fund’s largest reported positions or compare them to previous portfolio filings.

Diamond Hill Capital’s largest position was its 3.5 million shares of Occidental Petroleum Corporation (NYSE:OXY), up from the 2.9 million it had held at the end of the first quarter. Occidental is a large ($73 billion market cap) oil & gas exploration & production company. Occidental Petroleum Corporation (NYSE:OXY) has operations across the U.S. as well as in South America and the Middle East. The company trades at fairly low multiples, with both the trailing and forward P/E ratios being 12. Occidental has also been a favorite of other hedge funds; Ralph Whitworth’s Relational Investors owned 6 million shares at the end of March.

what is a hedge fund

The fund also owned 3.2 million shares of United Technologies Corporation (NYSE:UTX), up slightly from the 3 million it had held three months earlier. The conglomerate is responsible for products ranging from Otis elevators to aircraft engines and has lagged the market this year, up only 3%. The business has been stagnant recently but sell-side analysts expect enough growth in the next few quarters to push its forward P/E to 12. Dan Loeb’s Third Point initiated a large position in United Technologies Corporation (NYSE:UTX) in the first quarter of 2012.

The third largest holding in Diamond Hill’s portfolio according to the 13F filing was Abbott Laboratories (NYSE:ABT), a diversified healthcare company producing pharmaceuticals, diagnostics, and devices. The fund owned 3.7 million shares, roughly even with its position in the previous quarter. A number of statistics make Abbott Laboratories (NYSE:ABT) an attractive investment: including its 3.1% dividend yield, its forward P/E of 12, and its beta of 0.5. However, the company reported a decline in earnings in its most recent earnings announcement compared to the same period in 2011.

Pfizer Inc (NYSE:PFE) squeezed onto our list of the ten most popular stocks among hedge funds for the first quarter of 2012 at #10. Diamond Hill added a small number of shares to its portfolio to bring its position to 9.8 million shares, putting it at the #4 position for the fund. Pfizer Inc (NYSE:PFE) is another high-yielder in the healthcare sector with a 3.6% dividend yield, and its drug portfolio powered it to a 25% increase in earnings in its most recent quarter compared to the same quarter last year. Pfizer Inc (NYSE:PFE)’s trailing P/E is 18 and its forward multiple is only 10, with the company having beaten earnings expectations each of the last four quarters.

Rounding out Diamond Hill’s top five holdings is Medtronic Inc (NYSE:MDT), which the fund reported owning 5.8 million shares of as of the end of the second quarter (up from 5.4 million at the end of March). Medtronic Inc (NYSE:MDT) concentrates on cardiac and cardiovascular devices and reported good earnings growth in its most recent quarter but also returns good cash to its shareholders through a 2.6% dividend yield and trades at sub-teen multiples. Its trailing price-to-earnings ratio is 12 and the forward P/E if 10, making it another good value stock in the healthcare sector.

There wasn’t a lot of change in Diamond Hill’s portfolio this quarter. Three of its top five positions are healthcare related, but pay good dividends; United Technologies carries a 2.8% dividend yield as well. We think that Diamond Hill is biding its time in the market, collecting sure cash and waiting for the healthcare sector in particular to rally (or, alternatively, simply seeking downside protection in case of poor growth in the U.S.).

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!